Magnetic device for treating corneal exposure due to eyelid paralysis
Self-Adhering Magnetic Device to Treat Corneal Exposure
This study is testing a new magnetic device to help people with eyelid paralysis keep their eyes closed and prevent serious eye problems.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 25 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | University of Illinois at Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT06291818 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the use of a self-adhering magnetic device to treat corneal exposure resulting from paralytic lagophthalmos, a condition where patients cannot fully close their eyelids due to nerve paralysis. The study aims to evaluate the effectiveness of this innovative magnetic system in maintaining eyelid closure, thereby preventing complications such as corneal ulceration and potential blindness. By utilizing advancements in magnetic technology, the trial seeks to provide a more effective and aesthetically pleasing alternative to existing treatments, which often have limited success and poor patient compliance.
Who should consider this trial
Good fit: Ideal candidates include males and females aged 18-80 with lagophthalmos and recent corneal abrasions without signs of infection.
Not a fit: Patients with adhesive allergies, a history of metal in the eye, or current eye infections may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of life for patients suffering from corneal exposure by providing a reliable and user-friendly treatment option.
How similar studies have performed: Preliminary success has been reported in similar approaches using externally affixed magnets for eyelid closure, indicating potential for this novel treatment.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Males and females ages 18-80 years old. * Patients with recent corneal abrasion and no signs of infection in the examination * Patients with lagophthalmos * Normal Controls Exclusion Criteria: * Individuals with adhesive or tape allergies. * Individuals with a history of metal pieces/shavings embedded in the eye (such as from welding or metalworking) * Individuals with eye infections
Where this trial is running
Chicago, Illinois
- University of Illinois - Specialty Care Building — Chicago, Illinois, United States (Recruiting)
Study contacts
- Study coordinator: Pete Setabutr, MD
- Phone: 312-996-9120
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.